InvestorsHub Logo
Followers 66
Posts 4898
Boards Moderated 0
Alias Born 06/12/2014

Re: StockRoomBully post# 1

Thursday, 07/02/2020 8:59:57 AM

Thursday, July 02, 2020 8:59:57 AM

Post# of 174
Qualigen’s AS1411 cancer drug candidate uses synthetic DNA, known as an aptamer, to target and destroy tumor cells, without the serious side effects associated with other cancer therapies. In addition, in vitro studies recently performed at the University of Louisville demonstrated that AS1411 may protect cells from the harmful effects of SARS-CoV-2 infection (COVID-19).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent QLGN News